12th December 2019
The Queen Mary University of London professor leading an international breast cancer study says anastrozole – rather than tamoxifen – should be the preventive drug-of-choice for post-menopausal women at increased risk of developing the disease.
Read more3rd December 2019
A team of Barts Cancer Institute researchers from Professor Claude Chelala’s group took part in the NIHR Great Ormond Street Hospital Biomedical Research Centre Family Fun Day. The fun-filled afternoon provides an amazing opportunity for children, young people and their families to take part in fun, educational, hands-on activities and meet researchers.
Read more26th November 2019
Researchers from Barts Cancer Institute and Zhengzhou University have developed a personalised vaccine system that could ultimately delay the onset of pancreatic cancer. The study reports the team’s work with a pre-clinical model using mice, and provides strong proof-of-concept for the creation of a vaccine for cancer prevention in individuals at high risk of developing this disease.
Read more21st November 2019
This World Pancreatic Cancer Day, hear from some of our researchers about what they are working on to help combat this devastating cancer type.
Read more19th November 2019
Last month, Barts Cancer Institute’s Dr Bela Wrench hosted a session as part of the Bloodwise Lab Tour Programme, aimed at bringing current and potential supporters closer to research funded by the charity and to demonstrate the impact they can have in the fight against blood cancer.
Read more